NCT07165197

Visual Performance of Clareon Vivity and PureSee IOL

Visual Performance of Clareon® Vivity® and PureSee® Intraocular Lenses in Patients Undergoing Cataract Surgery

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 80 (estimated)
• Sponsor: OMIQ Research · Network
• Sex: All
• Age: 50 Years
• Healthy volunteers: Not accepted

Summary

This is study to determine the visual performance of patients with age-related cataracts implanted in both eyes with either of two extended depth of focus intraocular lenses, the Clareon Vivity (Alcon Healthcare) or the PureSee (Johnson \& Johnson)

Conditions

• Cataract

Interventions

Type	Name	Description
DEVICE	Phacoemulsification with implantation of an extended depth of focus intraocular lens	Comparison of two different Extended depth of focus intraocular lenses

Timeline

• Start date: 2025-06-27
• Primary completion: 2026-03-01
• Completion: 2026-03-01
• First posted: 2025-09-10
• Last updated: 2025-09-10

Locations

1 site across 1 country: Spain